| Labeling accuracy of cannabidiol extracts sold online MO Bonn-Miller, MJE Loflin, BF Thomas, JP Marcu, T Hyke, R Vandrey Jama 318 (17), 1708-1709, 2017 | 589 | 2017 |
| Cannabis pharmacology: the usual suspects and a few promising leads EB Russo, J Marcu Advances in pharmacology 80, 67-134, 2017 | 428 | 2017 |
| Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival JP Marcu, RT Christian, D Lau, AJ Zielinski, MP Horowitz, J Lee, A Pakdel, ... Molecular cancer therapeutics 9 (1), 180-189, 2010 | 223 | 2010 |
| Cannabinoid receptors: nomenclature and pharmacological principles L Console-Bram, J Marcu, ME Abood Progress in Neuro-Psychopharmacology and Biological Psychiatry 38 (1), 4-15, 2012 | 215 | 2012 |
| Pharmacological foundations of cannabis chemovars MA Lewis, EB Russo, KM Smith Planta medica 84 (04), 225-233, 2018 | 208 | 2018 |
| Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling DM Shore, GL Baillie, DH Hurst, F Navas, HH Seltzman, JP Marcu, ... Journal of biological chemistry 289 (9), 5828-5845, 2014 | 79 | 2014 |
| Differential Activation of Intracellular versus Plasmalemmal CB2 Cannabinoid Receptors GC Brailoiu, E Deliu, J Marcu, NE Hoffman, L Console-Bram, P Zhao, ... Biochemistry 53 (30), 4990-4999, 2014 | 65 | 2014 |
| An overview of major and minor phytocannabinoids JP Marcu Neuropathology of drug addictions and substance misuse, 672-678, 2016 | 35 | 2016 |
| Novel insights into CB1 cannabinoid receptor signaling: a key interaction identified between the extracellular-3 loop and transmembrane helix 2 J Marcu, DM Shore, A Kapur, M Trznadel, A Makriyannis, PH Reggio, ... Journal of Pharmacology and Experimental Therapeutics 345 (2), 189-197, 2013 | 32 | 2013 |
| Advances in pharmacology EB Russo, J Marcu Chapter Three-Cannabis Pharmacology: The Usual Suspects and a Few Promising …, 2017 | 30 | 2017 |
| Delta-8, a cannabis-derived tetrahydrocannabinol isomer: evaluating case report data in the Food and Drug Administration Adverse Event Reporting System (FAERS) database TA Simon, JH Simon, EG Heaning, A Gomez-Caminero, JP Marcu Drug, Healthcare and Patient Safety, 25-38, 2023 | 13 | 2023 |
| The professionalization of cannabis growing B Owens Nature 572 (7771), S10-S10, 2019 | 12 | 2019 |
| The legalization of cannabinoid products and standardizing cannabis-drug development in the United States: a brief report J Marcu Dialogues in Clinical Neuroscience 22 (3), 289-293, 2020 | 11 | 2020 |
| Molecular pharmacology of CB1 and CB2 cannabinoid receptors JP Marcu, JB Schechter Neuropathology of Drug Addictions and Substance Misuse, 713-721, 2016 | 10 | 2016 |
| Endocannabinoid regulation of monoamines in psychiatric and neurological disorders EJ Van Bockstaele Springer Science & Business Media, 2013 | 7 | 2013 |
| Regulators need to rethink restrictions on cannabis research. J Marcu Nature 572 (7771), S19-S19, 2019 | 6 | 2019 |
| Medical cannabis certification is associated with decreased opiate use in patients with chronic pain: a retrospective cohort study in Delaware A Balu, D Mishra, J Marcu, G Balu Cureus 13 (12), 2021 | 5 | 2021 |
| Case report: cannabidiol in the management of acute opioid withdrawal C Shaw, J Marcu Am J Endocannabinoid Med 3, 6-11, 2021 | 3 | 2021 |
| Alteratives to address cannabis intoxication in the workplace and clinical trials J Marcu, R Phifer ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 256, 2018 | 3 | 2018 |
| Current cannabinoid receptor nomenclature and pharmacological principles J Marcu, L Console-Bram, ME Abood Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological …, 2013 | 3 | 2013 |
MARY ABOODTemple University在 temple.edu 的电子邮件经过验证
